818 related articles for article (PubMed ID: 28217980)
21. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
Desai D; Lepe M; Baloch ZW; Mandel SJ
Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
[TBL] [Abstract][Full Text] [Related]
22. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
[TBL] [Abstract][Full Text] [Related]
23. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
[TBL] [Abstract][Full Text] [Related]
24. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
Rosario PW
Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
Strickland KC; Howitt BE; Marqusee E; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2015 Sep; 25(9):987-92. PubMed ID: 26114752
[TBL] [Abstract][Full Text] [Related]
26. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
27. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
28. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
Özkara SK; Bayrak BY; Turan G
Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
[TBL] [Abstract][Full Text] [Related]
29. Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study.
Rosario PW; Calsolari MR
Diagn Cytopathol; 2017 Jul; 45(7):604-607. PubMed ID: 28425211
[TBL] [Abstract][Full Text] [Related]
30. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology.
Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ
Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802
[TBL] [Abstract][Full Text] [Related]
31. Interobserver variability in inconclusive diagnostic categories of thyroid fine needle aspiration cytology: An urban-based tertiary hospital experience.
Sripodok S; Benjakul N
Ann Diagn Pathol; 2023 Apr; 63():152083. PubMed ID: 36657263
[TBL] [Abstract][Full Text] [Related]
32. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
33. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
Lale SA; Morgenstern NN; Chiara S; Wasserman P
Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
[TBL] [Abstract][Full Text] [Related]
34. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
35. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
36. Thyroid nodules classified as atypia or follicular lesions of undetermined significance deserve further research: Analysis of 305 surgically confirmed nodules.
Turkyilmaz S; Ulusahin M; Celebi B; Cekic AB; Mungan S; Kucuktulu U; Tasdelen A; Guner A; Cinel A
Cytopathology; 2017 Oct; 28(5):391-399. PubMed ID: 28714532
[TBL] [Abstract][Full Text] [Related]
37. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
[TBL] [Abstract][Full Text] [Related]
38. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
39. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
Li W; Sciallis A; Lew M; Pang J; Jing X
Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
[TBL] [Abstract][Full Text] [Related]
40. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
Marin F; Murillo R; Diego C; Jodar E; Acevedo A
Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
